BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 25759555)

  • 1. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.
    Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG
    World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.
    Sparr JA; Bandipalliam P; Redston MS; Syngal S
    Am J Surg Pathol; 2009 Feb; 33(2):309-12. PubMed ID: 18987546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal papillary mucinous neoplasm involving pancreaticobiliary maljunction and an aberrant pancreatic duct draining into the stomach: A case report and review of the literature.
    Kinowaki Y; Takazawa Y; Yamamoto N; Ishikawa Y
    Pathol Res Pract; 2016 Feb; 212(2):139-44. PubMed ID: 26611763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report.
    Verocq C; Racu ML; Bafort D; Butorano G; Perez-Casanova Garcia L; Navez J; Witterwulghe M; Sheahan K; Swan N; Closset J; Van Laethem JL; Maris C; D'Haene N
    Diagn Pathol; 2021 Dec; 16(1):117. PubMed ID: 34895278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas.
    Corcos O; Couvelard A; Dargère D; Sauvanet A; Hammel P; Paradis V; Lévy P; Ruszniewski P; Bedossa P
    Pancreas; 2012 Mar; 41(2):169-74. PubMed ID: 22076567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial intraductal papillary mucinous neoplasms of the pancreas.
    Rebours V; Couvelard A; Peyroux JL; Sauvanet A; Hammel P; Ruszniewski P; Lévy P
    Dig Liver Dis; 2012 May; 44(5):442-6. PubMed ID: 21824831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic Spleen-Preserving Total Pancreatectomy for a Main-Duct Intraductal Papillary Mucinous Neoplasm.
    Chapman BC; Paniccia A; Ryan C; Schulick RD; Edil BH
    Ann Surg Oncol; 2017 Feb; 24(2):560. PubMed ID: 27590330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
    Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous pancreatic solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm.
    Hirabayashi K; Zamboni G; Ito H; Ogawa M; Kawaguchi Y; Yamashita T; Nakagohri T; Nakamura N
    World J Gastroenterol; 2013 Jun; 19(21):3358-63. PubMed ID: 23745041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synchronous malignant intraductal papillary mucinous neoplasms of the bile duct and pancreas requiring left hepatectomy and total pancreatectomy].
    Moon DB; Lee SG; Jung DH; Park GC; Park YH; Park HW; Kim MH; Lee SK; Yu ES; Kim JH
    Korean J Gastroenterol; 2014 Feb; 63(2):129-33. PubMed ID: 24561701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.
    Daudé M; Muscari F; Buscail C; Carrère N; Otal P; Selves J; Buscail L; Bournet B
    World J Gastroenterol; 2015 Mar; 21(9):2658-67. PubMed ID: 25759534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
    Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
    J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
    Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
    Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Lupinacci RM; Goloudina A; Buhard O; Bachet JB; Maréchal R; Demetter P; Cros J; Bardier-Dupas A; Collura A; Cervera P; Scriva A; Dumont S; Hammel P; Sauvanet A; Louvet C; Delpéro JR; Paye F; Vaillant JC; André T; Closset J; Emile JF; Van Laethem JL; Jonchère V; Abd Alsamad I; Antoine M; Rodenas A; Fléjou JF; Dusetti N; Iovanna J; Duval A; Svrcek M
    Gastroenterology; 2018 Mar; 154(4):1061-1065. PubMed ID: 29158190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.
    Basturk O; Berger MF; Yamaguchi H; Adsay V; Askan G; Bhanot UK; Zehir A; Carneiro F; Hong SM; Zamboni G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Balci S; Allen P; Ikari N; Takeuchi S; Akagawa H; Kanno A; Shimosegawa T; Morikawa T; Motoi F; Unno M; Higuchi R; Yamamoto M; Shimizu K; Furukawa T; Klimstra DS
    Mod Pathol; 2017 Dec; 30(12):1760-1772. PubMed ID: 28776573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual CO2 MDCT pancreatography: a new feasible technique for minimally invasive pancreatectomy in intraductal papillary mucinous neoplasms.
    Sugimoto M; Yasuda H; Koda K; Suzuki M; Yamazaki M; Tezuka T; Kosugi C; Higuchi R; Takenoue T; Yamamoto S; Watayo Y; Yagawa Y; Tsuchiya T
    Hepatogastroenterology; 2008; 55(81):270-4. PubMed ID: 18507123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
    Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.